[Association between GNAS1 T393C polymorphism and therapeutic efficacy of tyrosine kinase inhibitor in pretreated advanced non-small cell lung cancer with unknown EGFR mutation status].
about
[Association between GNAS1 T393C polymorphism and therapeutic efficacy of tyrosine kinase inhibitor in pretreated advanced non-small cell lung cancer with unknown EGFR mutation status].
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
[Association between GNAS1 T39 ...... unknown EGFR mutation status].
@en
[Association between GNAS1 T39 ...... unknown EGFR mutation status].
@nl
type
label
[Association between GNAS1 T39 ...... unknown EGFR mutation status].
@en
[Association between GNAS1 T39 ...... unknown EGFR mutation status].
@nl
prefLabel
[Association between GNAS1 T39 ...... unknown EGFR mutation status].
@en
[Association between GNAS1 T39 ...... unknown EGFR mutation status].
@nl
P2093
P2860
P1476
[Association between GNAS1 T39 ...... unknown EGFR mutation status].
@en
P2093
Baochai Lin
Beibei Zhang
Weimin Mao
Yiping Zhang
P2860
P304
P356
10.3779/J.ISSN.1009-3419.2014.04.06
P407
P577
2014-04-01T00:00:00Z